Literature DB >> 11680592

Altered mucin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas.

K T Lee1, T S Liu.   

Abstract

Neoplastic transformation of epithelial cells is commonly associated with alterations in the synthesis and structures of mucin. Mucin protein epitopes and mRNA levels were frequently altered in adenocarcinomas compared to corresponding normal tissues. Clinically, hepatolithiasis has been regarded as a risk factor for cholangiocarcinoma. The aims of this study were to determine the possible alteration of mucin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas and to try to predict whether or not hepatolithiasis has a predisposition to development of cholangiocarcinoma. In situ hybridization with DIG-tailed oligonucleotides was performed on sections of paraffin-embedded tissues of stone-containing intrahepatic bile ducts, cholangiocarcinomas, and normal controls to identify the expression of MUC2, MUC3, MUC4, MUC5B, and MUC5AC in nonneoplastic and neoplastic biliary epithelium. The findings showed that (1) while multiple diverse mucin genes were expressed in the biliary epithelium, MUC3 and MUC5B mRNA were the main mucin genes expressed in the biliary epithelium of stone-containing intrahepatic bile ducts and normal controls; (2) absent or decreased expression of MUC2, MUC3, and MUC5B of mRNA was found in cholangiocarcinomas in contrast to nonneoplastic biliary epithelium; and (3) increased expression of MUC4 and MU5AC of mRNA was found in cholangiocarcinomas and the biliary epithelium, especially for dysplastic cells of stone-containing intrahepatic bile ducts compared with normal controls. In this study, using in situ hybridization we demonstrated that neoplastic transformation of the biliary epithelium is accompained by alterations in mucin gene expression, the altered mucin gene expression in dysplastic cells of stone-containing intrahepatic bile ducts may reflect a higher potential for malignant transformation in these cells, and it could be a precursor of cholangiocarcinoma in the presence of hepatolithiasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11680592     DOI: 10.1023/a:1011906830301

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  MUC5B is the prominent mucin in human gallbladder and is also expressed in a subset of colonic goblet cells.

Authors:  B J van Klinken; J Dekker; S A van Gool; J van Marle; H A Büller; A W Einerhand
Journal:  Am J Physiol       Date:  1998-05

2.  A lectin histochemical study of intrahepatic ducts in patients with hepatolithiasis.

Authors:  K T Lee; P C Sheen
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

3.  Diversity of mucin genes, structure, function, and expression.

Authors:  Y S Kim; J R Gum
Journal:  Gastroenterology       Date:  1995-09       Impact factor: 22.682

4.  Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma.

Authors:  Y Nakanuma; T Terada; Y Tanaka; G Ohta
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

5.  Mucin gene expression in biliary epithelial cells.

Authors:  B Vandenhaute; M P Buisine; V Debailleul; B Clément; N Moniaux; M C Dieu; P Degand; N Porchet; J P Aubert
Journal:  J Hepatol       Date:  1997-12       Impact factor: 25.083

6.  Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction.

Authors:  M Sasaki; Y Nakanuma; Y S Kim
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

7.  Human gastric mucin. Identification of a unique species by expression cloning.

Authors:  N W Toribara; A M Roberton; S B Ho; W L Kuo; E Gum; J W Hicks; J R Gum; J C Byrd; B Siddiki; Y S Kim
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

8.  Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7).

Authors:  L A Bobek; H Tsai; A R Biesbrock; M J Levine
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

9.  Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5).

Authors:  D Meezaman; P Charles; E Daskal; M H Polymeropoulos; B M Martin; M C Rose
Journal:  J Biol Chem       Date:  1994-04-29       Impact factor: 5.157

10.  Heterogeneity of mucin gene expression in normal and neoplastic tissues.

Authors:  S B Ho; G A Niehans; C Lyftogt; P S Yan; D L Cherwitz; E T Gum; R Dahiya; Y S Kim
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

View more
  9 in total

1.  MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma.

Authors:  Chanchai Boonla; Banchob Sripa; Peti Thuwajit; Ubon Cha-On; Anucha Puapairoj; Masanao Miwa; Sopit Wongkham
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

2.  Osteopontin Expression in Patients with Hepatolith.

Authors:  Bum Soo Kim; Sun Hyung Joo; Sung Jig Lim; Kwang Ro Joo
Journal:  Indian J Surg       Date:  2013-05-18       Impact factor: 0.656

3.  Mucin gene expression in bile of patients with and without gallstone disease, collected by endoscopic retrograde cholangiography.

Authors:  Alexander Vilkin; Alex Geller; Zohar Levi; Yaron Niv
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

Review 4.  Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review.

Authors:  Sreedevi Koppisetti; Bharat Jenigiri; M Pilar Terron; Sandra Tengattini; Hiroshi Tamura; Luis J Flores; Dun-Xian Tan; Russel J Reiter
Journal:  Dig Dis Sci       Date:  2008-03-13       Impact factor: 3.199

5.  Treatment of chronic proliferative cholangitis with c-myc shRNA.

Authors:  Fu-Yu Li; Nan-Sheng Cheng; Jing-Qiu Cheng; Hui Mao; Li-Sheng Jiang; Ning Li; Sheng He
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

6.  The expression and clinicopathological role of CDX2 in intrahepatic cholangiocarcinoma.

Authors:  Haowen Tang; Zhanbo Wang; Wenping Lv; Xuan Meng
Journal:  Intractable Rare Dis Res       Date:  2018-05

Review 7.  Is Osteopontin a Friend or Foe of Cell Apoptosis in Inflammatory Gastrointestinal and Liver Diseases?

Authors:  Tomoya Iida; Kohei Wagatsuma; Daisuke Hirayama; Hiroshi Nakase
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

8.  MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer.

Authors:  W R Matull; F Andreola; A Loh; Z Adiguzel; M Deheragoda; U Qureshi; S K Batra; D M Swallow; S P Pereira
Journal:  Br J Cancer       Date:  2008-05-13       Impact factor: 7.640

Review 9.  The diagnostic performance of serum MUC5AC for cholangiocarcinoma: A systematic review and meta-analysis.

Authors:  Ji Xuan; Jing Li; Zhirui Zhou; Renrong Zhou; Huabing Xu; Wei Wen
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.